A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19

  • 13k

    Total downloads

  • 54k

    Total views and downloads

About this Research Topic

Submission closed

Background

The recently reported outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes 2019 coronavirus disease (COVID-19), has led to a pandemic. This novel virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. COVID-19 is now affecting almost all countries around the world. The COVID-19 disease is a real health threat that is currently becoming a major concern worldwide and an unprecedented burden to public health. From the economy to social interactions, COVID-19 has affected almost every aspect of our society. Outbreaks such as avian flu, swine flu, Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola in Africa, and bluetongue in Europe are recent reminders.

COVID-19 affects different people in different ways. Most infected people develop mild to moderate disease and recover without hospitalization, but a subset of patients progress to severe disease, with high mortality rate and limited treatment options. The clinical feature of COVID-19 varies from asymptomatic forms to conditions involving multiorgan and systemic manifestations in terms of septic shock and multiple organ dysfunction syndromes (MODS). The main pathologic features of critical COVID-19 were consistent with acute lung injure (ALI) and acute respiratory distress syndrome (ARDS). This pathology involves direct attacks by the virus on the cells and secondary attacks on the body after activation of the immune system. This means that both the virus and the immune response can cause damage to the body, and common complications or secondary infection can occur. At cellular level, the spike protein (S-protein) of SARS-CoV-2 interacts with cell receptors to infect target cells. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) triggering endocytosis of virus particles. Consequently, ACE2 receptor would represent a potential therapeutic candidate to study SARS-CoV-2 infection mechanisms.

Treating COVID-19 patients is challenging as no specific treatment options or vaccines against SARS-CoV-2 are available. The current, supportive but not curative, treatments consist of the use of experimental medication. These include Remdesivir, hydroxychloroquine, abidol, lopinavir/ritonavir, plasma, antibody and other nonspecific vaccines. Currently, remdesivir appears to be the most promising drug for the treatment of pneumonia caused by COVID-19. Within this scenario, investigations are ongoing at a dizzying speed to achieve a vaccine, and the pioneering manufacturers of the vaccines ensure their rapid development (Moderna, CanSino-Biologics, Inovio, Sinovac, BioNTech-Pfizer, Univ. of Oxford-AstraZeneca, Novavax, Gamaleya Research Institute, CureVac, Clover Biopharmaceuticals, Johnson & Johnson, Sanofi-GlaxoSmithKline, Merck & Co.), even some are now being tested on people within clinical trials. Although important advances have been made, while waiting for the much-desired vaccines, no one knows how effective the new vaccines will be? Still, the development of feasible, safe and effective therapies is extremely urgent. Therefore, increasing experimental and clinical evidence have given credibility to the claim that advanced therapies research could change the future of COVID-19 and the forthcoming emergence of virulent viruses. Particularly, cell based-therapies will have an impact, not yet foreseen, on the present and future sequels of COVID-19.

On the one hand, recent studies focus on regenerative, immunomodulatory and anti-inflammatory properties of mesenchymal stromal cells (MSCs) to reduce the manifestation of cytokine storm and to restore ARDS and ALI, exhibiting an important option to be applied to critical COVID-19 patients; or on MSCs secretome to treat COVID-19 pneumonia. Other research includes the use of hematopoietic stem cells derived from umbilical cord blood, bone marrow, or mobilized peripheral blood, as well as immune chimeric antigen receptor T-cell (CAR-T cells). On the other hand, the understanding of the mechanism of infection and pathogenesis processes are still limited, in this regard the use of human pluripotent stem cells, both embryonic stem cells (hESC) and/or induced stem cells (hiPSC) to generate tissue-specific human organoids (lung, intestinal, liver, vascular, heart and kidney organoids) may provide a next generation cellular model for investigating viral infection and drug screening.

Altogether, the main propose of this Research Topic is to highlight recent advances, to cover the progress of preclinical and clinical research and to discuss the critical aspects to be considered for the application of stem cell to palliate the COVID-19. The topic is broad and covers all aspects related to COVID-19. Although the main focus is on stem cell-based application for COVID-19, research articles reporting on other aspects of SARS-CoV-2, such as its structure, function, mechanism of infection, interaction with the receptor of host cells (SARS-CoV-2-ACE2), the detection of new therapeutic target and the development of new detection tools are appreciated.

This Research Topic accepts original researches, reviews, methods, clinical trials, case reports, letters to the editor, brief research reports, commentaries and opinions.

Keywords: Covid-19, cell therapy, SARS-CoV-2, spike-protein

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 54kTopic views
  • 34kArticle views
  • 13kArticle downloads
View impact